⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6421859 | 0.70 | — | — | |
| SCHEMBL3226239 | 0.67 | — | — | |
| SCHEMBL294459 | 0.67 | — | — | |
| SCHEMBL9505042 | 0.64 | — | — | |
| SCHEMBL9404015 | 0.64 | — | — | |
| SCHEMBL292276 | 0.64 | — | — | |
| SCHEMBL10778537 | 0.64 | — | — | |
| Vinyl Chloride SCHEMBL11779557 | 0.60 | — | — | |
| SCHEMBL5248006 | 0.60 | — | — | |
| SCHEMBL7369197 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10927071-B2 | Process for preparing electron deficient olefins | Henkel IP & Holding GmbH (DE) | 2021-02-23 | — | — | US | claimed |
| EP-3558934-A1 | PROCESS FOR PREPARING ELECTRON DEFICIENT OLEFINS | Henkel IP & Holding GmbH (DE) | 2019-10-30 | — | — | EP | claimed |
| US-20190292141-A1 | PROCESS FOR PREPARING ELECTRON DEFICIENT OLEFINS | HENKEL AG & CO. KGAA (DE) | 2019-09-26 | — | — | US | claimed |
| US-20180340008-A1 | ANTIBIOTIC OLIGOPEPTIDE MIMETICS | BIOXINESS PHARMACEUTICALS INC (US) | 2018-11-29 | — | — | US | claimed |
| WO-2018114458-A1 | PROCESS FOR PREPARING ELECTRON DEFICIENT OLEFINS | Henkel IP & Holding GmbH (DE) | 2018-06-28 | — | — | WO | claimed |
| US-7223757-B2 | Tyrosine kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-05-29 | — | — | US | claimed |
| US-7067658-B2 | Pyridino and pyrimidino pyrazinones | BRISTOL-MYERS SQUIBB COMPANY (US) | 2006-06-27 | — | — | US | claimed |
| US-20060079518-A1 | Novel tyrosine kinase inhibitors | WITTMAN MARK D | 2006-04-13 | — | — | US | claimed |
| US-20040082784-A1 | Pyridino and pyrimidino pyrazinones | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2004-04-29 | — | — | US | claimed |
| WO-2004031189-A1 | PYRIDINO AND PYRIMIDINO PYRAZINONES FOR TREATMENT OF ANXIETY AND DEPRESSION | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2004-04-15 | — | — | WO | claimed |
| US-20040044203-A1 | Novel tyrosine kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2004-03-04 | — | — | US | claimed |
| US-6693123-B2 | (4-(3-PYRIDYLAMINOMETHYLENE)-2-PHENYLBENZOYL)-N -METHYLMETHIONINE, METHYL ESTER FOR EXAMPLE; RESTENOSIS, HYPERPLASIA | UNIVERSITY OF PITTSBURGH | 2004-02-17 | — | — | US | claimed |
| US-20040006093-A1 | Compounds which inhibit leukocyte adhesion mediated by VLA-4 | BIOGEN IDEC INTERNATIONAL HOLDING LTD. (BM) | 2004-01-08 | — | — | US | claimed |
| US-6583139-B1 | Treatment of inflammatory diseases; inflammatory brain diseases such as multiple sclerosis; N-(Toluene-4-sulfonyl)-L-prolyl-4-(alpha -methylbenzyloxy)-L-phenylalanine; Very Late Antigen 4 | BIOGEN IDEC INTERNATIONAL HOLDING LTD. (BM) | 2003-06-24 | — | — | US | claimed |
| EP-0994896-A1 | SULFONYLATED DIPEPTIDE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | Elan Pharmaceuticals, Inc. (US) | 2000-04-26 | — | — | EP | claimed |
| WO-1999006437-A1 | SULFONYLATED DIPEPTIDE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | ELAN PHARMACEUTICALS INC. (US) | 1999-02-11 | — | — | WO | claimed |
| EP-3689979-B1 | CATIONIC ELECTRODEPOSITION COATING COMPOSITION | KANSAI PAINT CO LTD (JP) | 2024-01-31 | — | — | EP | disclosed |
| EP-3558935-B1 | PROCESS FOR PREPARING ELECTRON DEFICIENT OLEFINS | HENKEL AG & CO KGAA (DE) | 2023-11-29 | — | — | EP | disclosed |
| WO-1995010519-A1 | QUINOLIZINONE TYPE COMPOUNDS | ABBOTT LABORATORIES (US) | 1995-04-20 | — | — | WO | disclosed |
| WO-1994007518-A1 | ANAPHYLATOXIN RECEPTOR LIGANDS CONTAINING LIPOPHILIC RESIDUES | ABBOTT LABORATORIES (US) | 1994-04-14 | — | — | WO | disclosed |